KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 19 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $843,381 | -9.1% | 1,359 | 0.0% | 0.01% | -16.7% |
| Q2 2023 | $927,518 | -82.7% | 1,359 | -100.0% | 0.01% | -81.2% |
| Q1 2022 | $5,349,000 | +3.6% | 6,313,000 | 0.0% | 0.06% | +73.0% |
| Q4 2021 | $5,161,000 | +57.2% | 6,313,000 | +44.7% | 0.04% | +32.1% |
| Q3 2021 | $3,284,000 | -60.4% | 4,363,000 | -33.7% | 0.03% | -61.6% |
| Q4 2020 | $8,286,000 | +24.2% | 6,579,000 | +17.9% | 0.07% | -45.1% |
| Q3 2020 | $6,671,000 | -14.7% | 5,579,000 | 0.0% | 0.13% | -48.2% |
| Q2 2020 | $7,819,000 | -10.0% | 5,579,000 | -8.0% | 0.26% | -25.1% |
| Q1 2020 | $8,689,000 | -22.5% | 6,063,000 | -22.7% | 0.34% | +68.1% |
| Q4 2019 | $11,213,000 | – | 7,845,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 9,000,000 | $7,529,000 | 3.08% |
| Context Capital Management, LLC | 16,700 | $13,919,000 | 0.90% |
| Opti Capital Management, LP | 11,460,000 | $9,548,000 | 0.77% |
| DeepCurrents Investment Group LLC | 22,500,000 | $18,593,000 | 0.58% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 31,050,000 | $24,245,000 | 0.56% |
| PenderFund Capital Management Ltd. | 1,500,000 | $1,615,000 | 0.40% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 25,000,000 | $20,932,000 | 0.27% |
| AQR Arbitrage LLC | 9,900,000 | $8,388,000 | 0.22% |
| CSS LLC/IL | 5,000,000 | $4,154,000 | 0.15% |
| Verition Fund Management LLC | 6,313,000 | $5,349,000 | 0.06% |